Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Decision support for organ offers in liver transplantation.
Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
Response to letter to the editors.
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
